المؤلفون: Carolina, López-Guzmán, Jaime, Carmona-Fonseca

المصدر: Revista Peruana de Medicina Experimental y Salud Pública, Vol 37, Iss 2, Pp 220-8 (2020)

مصطلحات موضوعية: lcsh:R5-920, placenta, lcsh:R, malaria, lcsh:Medicine, mediador, plasmodium, Pregnancy, parasitic diseases, colombia, Humans, Female, Malaria, Falciparum, patología, lcsh:Medicine (General), histopatología, Physiological Phenomena

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::0c3b34033ec22eccbf596071a533a124Test
https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/4759Test

المؤلفون: Jaime Carmona-Fonseca, Eliana Arango, Silvia Blair

المصدر: Biomédica: revista del Instituto Nacional de Salud, Vol 28, Iss 2, Pp 195-212 (2008)

مصطلحات موضوعية: malaria/ therapy, malaria, falciparum, Plasmodium falciparum, antimalarials, amodiaquine, sulfadoxine, pyrimethamine, Artemisia annua, Medicine, Arctic medicine. Tropical medicine, RC955-962

وصف الملف: electronic resource

العلاقة: http://www.revistabiomedica.org/index.php/biomedica/article/view/91Test; https://doaj.org/toc/0120-4157Test

الوصول الحر: https://doaj.org/article/44f0f8e34b594240af1fbdb62a2e50e8Test

المؤلفون: Marquiño Quesada, Wilmer Oswaldo

المصدر: Instituto Nacional de Salud ; Repositorio Institucional - INS

مصطلحات موضوعية: Malaria, Malaria Falciparum, Brote de Enfermedades, Vigilancia Epidemiológica

وصف الملف: application/pdf

العلاقة: Bol. Inst. Nac. Salud;4-5(9-10):66-67, 1998-1999. tab.; Marquiño-Quesada WO. Aportes del Instituto Nacional de Salud para el control de la malaria en el Perú. Bol. Inst. Nac. Salud. 1998-1999;4-5(9-10):66-7.; https://hdl.handle.net/20.500.14196/866Test

الإتاحة: https://doi.org/20.500.14196/866Test
https://hdl.handle.net/20.500.14196/866Test

المؤلفون: Ana María Vásquez, Alexandra Ríos, Alberto Tobón, Luis Gonzalo Álvarez, Silvia Blair, Felipe Sanín

المصدر: Biomédica: revista del Instituto Nacional de Salud, Vol 29, Iss 2, Pp 307-319 (2009)

مصطلحات موضوعية: medicine.medical_specialty, Primaquine, lcsh:Arctic medicine. Tropical medicine, primaquine, lcsh:RC955-962, malaria, lcsh:Medicine, General Biochemistry, Genetics and Molecular Biology, chemistry.chemical_compound, falciparum, medicine, Patient compliance, Gynecology, Mefloquina, biology, business.industry, mefloquine, lcsh:R, Plasmodium falciparum, biology.organism_classification, medicine.disease, Artesunate + mefloquine, chemistry, Artesunate, treatment outcome, artesunate, business, Malaria falciparum, Malaria, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5de8e93c5afa1eedf2e2d139f301f7fTest
http://www.revistabiomedica.org/index.php/biomedica/article/view/32Test

المؤلفون: Eliana Arango, Jaime Carmona-Fonseca, Silvia Blair

المصدر: Biomédica: revista del Instituto Nacional de Salud, Vol 28, Iss 2, Pp 195-212 (2008)

مصطلحات موضوعية: Sulfadoxina, sulfadoxine, medicine.medical_specialty, lcsh:Arctic medicine. Tropical medicine, Sulfadoxine, lcsh:RC955-962, medicine.medical_treatment, Plasmodium falciparum, lcsh:Medicine, Amodiaquine, Artemisia annua, malaria/ therapy, General Biochemistry, Genetics and Molecular Biology, antimalarials, chemistry.chemical_compound, medicine, Gametocyte, malaria, falciparum, Gynecology, biology, Traditional medicine, business.industry, lcsh:R, medicine.disease, biology.organism_classification, pyrimethamine, Pyrimethamine, amodiaquine, chemistry, Artesunate, business, Malaria, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4754954da8c14cf6aa64a88881cc4bbTest
http://www.revistabiomedica.org/index.php/biomedica/article/view/91Test

المؤلفون: Carmona-Fonseca, Jaime, Arango, Eliana, Blair, Silvia

المصدر: Biomedica; Vol. 28 No. 2 (2008); 195-212 ; Biomédica; Vol. 28 Núm. 2 (2008); 195-212 ; 2590-7379 ; 0120-4157

مصطلحات موضوعية: malaria/ terapia, malaria falciparum, Plasmodium falciparum, antipalúdicos, amodiaquina, sulfadoxina, pirimetamina, Artemisia annua, malaria/ therapy, malaria, falciparum, antimalarials, amodiaquine, sulfadoxine, pyrimethamine

وصف الملف: application/pdf

العلاقة: https://revistabiomedica.org/index.php/biomedica/article/view/91/89Test; Day KP, Hayward RE, Dyer M. The biology of Plasmodium falciparum transmission stages. Parasitology. 1998; 116 ( Suppl.): S95-109. 2. Eichner M, Diebner HH, Molineaux L, Collins WE, Jeffery GM, Dietz K. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg. 2001; 95: 497-501. 3. Robert V, Boudin C. Biologie de la transmission homme-moustique du Plasmodium. Bull Soc Pathol Exot. 2003; 96: 6-20. 4. Field JW, Shute PG. The microscopic diagnostic of human malaria. In: A morphological study of the erythrocytic parasites. Kuala Lumpur: Government Press; 1956. p. 142. 5. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V. Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J. 2004; 3: 24. 6. Rogers NJ, Hall BS, Obiero J, Targett GA, Sutherland CJ. A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. Infect Immun. 2000; 68: 3455-62. 7. Lensen A, Bril A, van de Vegte M, van Gemert GJ, Eling W, Sauerwein R. Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. Exp Parasitol. 1999; 91: 101-3. 8. Sinden RE, Smalley ME. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology. 1979; 79: 277-96. 9. Smalley ME, Sinden RE. Plasmodium falciparum gametocytes their longevity and infectivity. Parasitology. 1977; 74: 1-8. 10. Drakeley C, Sutherland C, Bousema JT, Sauerwein RW, Targett GA. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol. 2006; 22: 424-30. 11. Carter R, Miller LH. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull World Health Organ. 1979; 57 ( Suppl.1): 37-52. 12. Dyer M, Day KP. Commitment to gametocytogenesis in Plasmodium falciparum. Parasitol Today. 2000; 16: 102-7. 13. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, et al. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001; 83: 1254-9. 14. Sowunmi A, Fateye BA. Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop Med Int Health. 2003; 8: 783-92. 15. von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G. Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg. 2001; 65: 523-7. 16. von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G, Targett G. Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Trop Med Int Health. 2001; 6: 92-8. 17. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, et al. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med. 2005; 2: e92. 18. Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, Randall A, et al. Chloroquine-sulphadoxine-pyrimethamine for uncomplicated malaria in Gambian children: enhanced transmission to mosquitoes of multi-drug-resistant Plasmodium falciparum. PloS Clin Trials. 2006; 1: e15. 19. Contreras-Ochoa C, Ramsey JM. Gametocitos de Plasmodium vivax y Plasmodium falciparum: estadios olvidados en el desarrollo de vacunas. Salud Pública Mex. 2004; 46: 64-70. 20. Carmona-Fonseca J. Profilaxis primaria con primaquina para el paludismo. Revisión. Anuario Enfermedades Infecciosas (Medellín). 2004; 2: 51-84. 21. Litter M. Compendio de farmacología. Cuarta edición. Buenos Aires: El Ateneo; 1988. p. 794-805. 22. Grewal RS. Pharmacology of 8-aminoquinolines. Bull World Health Organ. 1981; 59: 397-406. 23. Ponsa N, Sattabongkot J, Kittayapong P, Eikarat N, Coleman RE. Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of Plasmodium vivax in Thailand. Am J Trop Med Hyg. 2003; 69: 542-7. 24. López-Antuñano FJ. Is primaquine useful and safe as true exo-erythrocytic meronticidal, hyponociticial and gametocidal antimalarial drugs? Salud Pública Mex. 1999; 41: 410-9. 25. Portela MJ, Moreira R, Valente E, Constantino L, Iley J, Pinto J, et al. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates. Pharm Res. 1999; 16: 949-55. 26. Coleman RE, Nath AK, Schneider I, Song GH, Klein TA, Milhous WK. Prevention of sporogony of Plasmodium falciparum and P. berghei in Anopheles stephensi mosquitoes by transmission-blocking antimalarials. Am J Trop Med Hyg. 1994; 50: 646-53. 27. Shao BR, Ye XY. Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys. Southeast Asian J Trop Med Public Health. 1991; 22: 81-3. 28. Rastogi M, Pal NL, Sen AB. Gametocytocidal and sporontocidal activity of some standard antimalarials on P. berghei (NK 65) infection M. natalensis. Indian J Malariol. 1989; 26: 9-18. 29. Teklehaimanot A, Nguyen-Dinh P, Collins WE, Barber AM, Campbell CC. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro. Am J Trop Med Hyg. 1985; 34: 429-34. 30. Gotay NJ, Kamtekar KD, Dalvi SS, Mehta SS, Chogle AR, Aigal U, et al. A randomized, parallel study of the safety and efficacy of 45 mg primaquine versus 75 mg bulaquine as gametocytocidal agents in adults with blood schizonticide-responsive uncomplicated falciparum malaria ISCRTN50134587. BMC Infect Dis. 2006; 6: 16. 31. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Antimicrob Agents Chemother. 2004; 48: 1329-34. 32. Kamtekar KD, Gogtay NJ, Dalvi SS, Karnad DR, Chogle AR, Aigal U, et al. A prospective study evaluating the efficacy of a single, 45-mg dose of primaquine, as a gametocytocidal agent, in patients with Plasmodium falciparum malaria in Mumbai, India. Ann Trop Med Parasitol. 2004; 98: 453-8. 33. Gogtay NJ, Chogle AR, Sorabjee JS, Marathe SN, Kshirsagar NA. Poor gametocytocidal activity of 45 mg primaquine in chloroquine-treated patients with acute, uncomplicated, P. falciparum malaria in Mumbai (Bombay): an issue of public-health importance. Ann Trop Med Parasitol. 1999; 93: 813-6. 34. Kaneko A, Kamei K, Suzuki T, Ishii A, Siagian R, Panjaitan W. Gametocytocidal effect of primaquine in a chemotherapeutic malaria control trial in North Sumatra, Indonesia. Southeast Asian J Trop Med Public Health. 1989; 20: 351-9. 35. Chomcharn Y, Surathin K, Bunnag D, Sucharit S, Harinasuta T. Effect of a single dose of primaquine on a Thai strain of Plasmodium falciparum. Southeast Asian J Trop Med Public Health. 1980; 11: 408-12. 36. World Health Organization. Guidelines for the treatment of malaria. WHO/HTM/MAL/2006.1108. Geneva: WHO; 2006. 37. Kshirsagar NA. Malaria: anti malarial resistance and policy ramifications and challenges. J Postgrad Med. 2006; 52: 291-3. 38. Carmona-Fonseca J. La primaquina tiene alta eficacia en la quimioprofilaxis primaria simple antipalúdica. Metanálisis. Iatreia. 2006; 19: 244-60. 39. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AL. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis. I Am J Trop Med Hyg 2006; 75: 402-15. 40. Marquiño W, Ylquimiche L, Hermenegildo Y, Palacios AM, Falconi E, Cabezas C, et al. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru. Am J Trop Med Hyg. 2005; 72: 568-72. 41. Mockenhaupt FP, Ehrhardt S, Dzisi SY, Teun Bousema J, Wassilew N, Schreiber J, et al. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop Med Int Health. 2005; 10: 512-20. 42. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N. International Artemisinin Study Group. Artesunate combinations for treatment of malaria: meta-analysis. Lancet. 2004; 363: 9-17. 43. Nacher M, Silachamroon U, Singhasivanon P, Wilairatana P, Phumratanaprapin W, Fontanet A, et al. Comparison of artesunate and chloroquine activities against Plasmodium vivax gametocytes. Antimicrob Agents Chemother. 2004; 48: 2751-2. 44. Abacassamo F, Enosse S, Aponte JJ, Gomez-Olive FX, Quinto L, Mabunda S, et al. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Trop Med Int Health. 2004; 9: 200-8. 45. Chen PQ, Li GQ, Guo XB, He KR, Fu YX, Fu LC, et al. The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J (Engl). 1994; 107: 709-11. 46. White NJ. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci. 1999; 354: 739-49. 47. Schneider P, Bousema T, Omar S, Gouagna L, Sawa P, Schallig H, et al. (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int J Parasitol. 2006; 36: 403-8. 48. Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA, Bamgboye AE, Babalola CP, et al. Effects of antifolates-co-trimoxazole and pyrimethamine-sulfadoxine-on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria. Mem Inst Oswaldo Cruz. 2005; 100: 451-5. 49. Sowunmi A, Fateye BA, Happi TC, Gbotosho GO, Oduola AM. Plasmodium falciparum gametocytaemia in Nigerian children: Peripheral immature gametocytaemia as an indicator of a poor response to chloroquine treatment, and its relationship to molecular determinants of chloroquine resistance. Ann Trop Med Parasitol. 2003; 97: 453-68. 50. Sowunmi A, Fateye BA. Gametocyte sex ratios in children with asymptomatic, recrudescent, pyrimethamine- sulfadoxine-resistant, Plasmodium falciparum malaria. Ann Trop Med Parasitol. 2003; 97: 671-82. 51. Sokhna CS, Trape JF, Robert V. Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine. Parasite. 2003; 8: 243-50. 52. Puta C, Manyando C. Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Trop Med Int Health. 1997; 2: 227-9. 53. Tin F, Nyunt- Hlaing. Comparative drug trial of a sulfadoxine/pyrimethamine and a sulfalene/pyrimethamine combination against Plasmodium falciparum infections in semi-immune populations of Burma. Southeast Asian J Trop Med Public Health. 1984; 15: 238-48. 54. Robert V, Read AF, Essong J, Tchuinkam T, Mulder B, Verhave JP, et al. Effect of gametocyte sex ratio on infectivity of Plasmodium falciparum to Anopheles gambiae. Trans R Soc Trop Med Hyg. 1996; 90: 621-4. 55. Bukirwa H, Critchley J. Sulfadoxine-pyrimethamine plus artesunate versus sulfadoxine-pyrimethamine plus amodiaquine for treating uncomplicated malaria. Cochrane Database Sys Rev. 2006; 25: CD004966. 56. Ali E, Mackinnon MJ, Abdel-Muhsin AM, Ahmed S, Walliker D, Babiker HA. Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. Trans R Soc Trop Med Hyg. 2006; 100: 176-83. 57. Robert V, Awono-Ambene HP, Le Hesran JY, Trape JF. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am J Trop Med Hyg. 2000; 62: 210-6. 58. Handunnetti SM, Gunewardena DM, Pathirana PP, Ekanayake K, Weerasinghe S, Mendis KN. Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Trans R Soc Trop Med Hyg. 1996; 90: 563-7. 59. Hogh B, Gamage-Mendis A, Butcher GA, Thompson R, Begtrup K, Mendis C, et al. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg. 1998; 58: 176-82. 60. Schneider P, Schoone G, Schallig H, Verhage D, Telgt D, Eling W, et al. Quantification of Plasmodium falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol Biochem Parasitol. 2004; 137: 35-41. 61. Arango E, Álvarez T, Carmona J, Blair S. Gametocitemia de Plasmodium falciparum según la respuesta terapéutica a sulfadoxina-pirimetamina y cloroquina en dos municipios de Antioquia, Colombia. Biomédica. 2004; 24: 79-88. 62. Osorio L, González I, Olliaro P, Taylor WR. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Malar J. 2007; 286: 25. 63. Osorio L, Ferro BE, Castillo CM. Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia. Mem Inst Oswaldo Cruz. 2002; 97: 1221-3. 64. Méndez F, Muñoz A, Carrasquilla G, Jurado D, Arévalo-Herrera M, Cortese JF, et al. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Trop Med Hyg. 2002; 156: 230-8. 65. Carmona-Fonseca J, Álvarez G, Blair S. Malaria por Plasmodium vivax: curación del ataque agudo con tres dosis diferentes de primaquina y dosis fija de cloroquina; Antioquia (Colombia), 2003-2004. Biomédica. 2006; 26: 353-65. 66. Blair S, Tobón A, Echeverri M, Álvarez G, Carmona-Fonseca J. Adecuada respuesta clínica y parasitológica de Plasmodium vivax a la cloroquina en Colombia (Turbo, Antioquia), 2001. Infectio. 2002; 6: 21-6. 67. Lacharme L, Carmona-Fonseca J, Tobón A, Blair S. Respuesta de P. vivax al esquema terapéutico cloroquina-primaquina en Zaragoza y Turbo, Colombia, 1998. Infectio. 1998; 2: 90-4. 68. Blair S, Carmona-Fonseca J, Piñeros JG, Ríos A, Álvarez T, Álvarez G, et al. Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia. Malar J. 2006; 5: 14. 69. Carmona-Fonseca J, Tobón A, Álvarez G, Blair S. El tratamiento amodiaquina-sulfadoxina-pirimetamina tiene eficacia del 98% para la malaria falciparum no complicada (Antioquia, Colombia; 2003). Iatreia. 2005; 18: 5-27. 70. Carmona-Fonseca J. La malaria en Colombia, Antioquia y las zonas de Urabá y Bajo Cauca: panorama para interpretar la falla terapéutica antimalárica Parte 1. Iatreia. 2003; 16: 299-318. 71. Carmona-Fonseca J. La malaria en Colombia, Antioquia y las zonas de Urabá y Bajo Cauca: panorama para interpretar la falla terapéutica antimalárica. Parte 2. Iatreia. 2004; 17: 34-53. 72.Carmona-Fonseca J. Malaria, desnutrición y parasitosis intestinal en los niños colombianos: interrelaciones. Iatreia. 2004; 17: 354-69. 73. Organización Mundial de la Salud, Organización Panamericana de la Salud. Evaluación de la eficacia terapéutica de los medicamentos para el tratamiento del paludismo por Plasmodium falciparum sin complicaciones en las Américas. Documento OPS/HCP/HCT/113/98. Washington: OPS; 1998. 74. López-Antuñano FJ, Schmunis G. Diagnótico de malaria. Publicación científica No. 512. Washington DC: OPS; 1988. 75. Ministerio de Salud. Guía de atención clínica para el diagnóstico y tratamiento de la malaria. Bogotá: Instituto Nacional de Salud; 1999. 76. Baird JK, Fryauff DJ, Hoffmann SL. Primaquine for prevention of malaria in travelers. Clin Infect Dis. 2003; 37: 1659-67. 77. Villa-Restrepo AF. Mutaciones puntuales en los genes dhps y dhfr de Plasmodium falciparum asociadas con la respuesta terapéutica a sulfadoxina-pirimetamina en Antioquia-Colombia. (Tesis). Medellín: Grupo Malaria, Corporación de Ciencias Básicas Biomédicas, Universidad de Antioquia; 2005. 78. Suputtamongkol Y, Chindarat S, Silpasakorn S, Chaikachonpatd S, Lim K, Chanthapakajee K, et al. The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of Plasmodium falciparum gametocytemia. Am J Trop Med Hyg. 2003; 68: 620-3. 79. van den Broek IV, Maung UA, Peters A, Liem L, Kamal M, Rahman M, et al. Efficacy of chloroquine+sulfadoxine-pyrimethamine, mefloquine+artesunate and artemether+lumefantrine combination therapies to treat Plasmodium falciparum malaria in the Chittagong Hill Tracts, Bangladesh. Trans R Soc Trop Med Hyg. 2005; 99: 727-35. 80. Ávila JC, Villaroel R, Marquino W, Zegarra J, Mollinedo R, Ruebush TK. Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia. Trop Med Int Health. 2004; 9: 217-22. 81. Marquiño W, Huilca M, Calampa C, Falconi E, Cabezas C, Naupay R, et al. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru. Am J Trop Med Hyg. 2003; 68: 608-12. 82. Omari AA, Gamble C, Garner P. Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Sys Rev. 2005; 19: CD005564. 83. Guthmann JP, Cohuet S, Rigutto C, Fortes F, Saraiva N, Kiguli J, et al. High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg. 2006; 75: 143-5. 84. Peters W, Stewart LB, Robinson BL. The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines. Ann Trop Med Parasitol. 2003; 97: 221-36. 85. Lederman ER, Maguire JD, Sumawinata IW, Chand K, Elyazar I, Estiana L, et al. Combined chloroquine, sulfadoxine/pyrimethamine and primaquine against Plasmodium falciparum in Central Java, Indonesia. Malar J. 2006; 5: 108. 86. Bunnag D, Harinasuta T, Pinichpongse S, Suntharasami P. Effect of primaquine on gametocytes of Plasmodium falciparum in Thailand. Lancet. 1980; 2: 91. 87. Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, et al. Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE. 2007; 2: e1023.; https://revistabiomedica.org/index.php/biomedica/article/view/91Test

الإتاحة: https://revistabiomedica.org/index.php/biomedica/article/view/91Test

المؤلفون: Osorio, Lyda, Pérez, Ligia del Pilar, González, Iveth J.

المصدر: Biomedica; Vol. 27 No. 1 (2007); 133-40 ; Biomédica; Vol. 27 Núm. 1 (2007); 133-40 ; 2590-7379 ; 0120-4157

مصطلحات موضوعية: malaria, falciparum/prevention & control, malaria vivax/prevention & control, drug therapy, Amazonian ecosystem, Colombia, malaria falciparum/prevención y control, malaria vivax/prevención y control, quimioterapia, ecosistema amazónico

وصف الملف: application/pdf

العلاقة: https://revistabiomedica.org/index.php/biomedica/article/view/239/224Test; Zambrano P. Informe final de malaria, semanas 1 a 52 Colombia, 2005. Inf Quinc Epidemiol Nac 2006;11:49-53. 2. Moore DV, Lanier JE. Observations of two Plasmodium falciparum infections with an abnormal response to chloroquine. Am J Trop Med Hyg 1961;10:5-9. 3. López Y, Arroyave A, Salazar A. Evaluación de la resistencia in vivo a los medicamentos antimaláricos El Bagre, Antioquia, 1998. Rev Epidemiol Antioquia 1999;24:181-94. 4. Blair S, Lacharme L, Carmona J, Tobón A. Resistencia de Plasmodium falciparum a tres fármacos antimaláricos en Turbo (Antioquia, Colombia) 1998. Rev Panam Salud Pública 2001;9:23-9. 5. Blair S, Lacharme-Lora L, Carmona-Fonseca J. Resistance of Plasmodium falciparum to antimalarial drugs in Zaragoza (Antioquia, Colombia), 1998. Mem Inst Oswaldo Cruz 2002;97:401-6. 6. Castillo CM, Osorio LE, Palma GI. Assessment of the therapeutic response of Plasmodium vivax and Plasmodium falciparum to chloroquine in a malaria transmission free area in Colombia. Mem Inst Oswaldo Cruz 2002;97:559-62. 7. Osorio LE, Giraldo LE, Grajales LF, Arriaga AL, Andrade AL, Ruebush TK 2nd et al. Assessment of therapeutic response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in a low malaria transmission area in Colombia. Am J Trop Med Hyg 1999;61:968-72. 8. Ministerio de Salud de Colombia. Guía de atención clínica para el diagnóstico y tratamiento de la malaria. Bogotá: Ministerio de Salud; 1999. 9. Alecrim M das G, Alecrim WD, de Albuquerque BC, Dourado HV, Wanssa M do C. Resistance of Plasmodium falciparum in the Brazilian Amazonas to the combination of sulfadoxine and pyrimethamine. Rev Inst Med Trop Sao Paulo 1982;24 (6 suppl):44-7. 10. Magill AJ, Zegarra J, Garcia C, Marquino W, Ruebush TK 2nd. Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru. Rev Soc Bras Med Trop 2004;37:279-81. 11. Alecrim M das G, Alecrim W, Macedo V. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev Soc Bras Med Trop 1999;32:67-8. 12. Baird JK, Wiady I, Fryauff DJ, Sutanihardja MA, Leksana B, Widjaya H et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am J Trop Med Hyg 1997;56:627-31. 13. Soto J, Toledo J, Gutiérrez P, Luzz M, Llinas N, Cedeño N et al. Plasmodium vivax clinically resistant to chloroquine in Colombia. Am J Trop Med Hyg 2001;65:90-3. 14. World Health Organization. Assessment and monitoring of antimalarial drug efficacy for the treatment of of uncomplicated P. falciparum malaria. Report No.: WHO/HTM/RBM/2003.50. Geneva: WHO; 2003. 15. World Health Organization/Pan American Health Organization. Assessment of therapeutic efficacy of medicaments to treat uncomplicated P. falciparum malaria in the Americas. Report No.: PS/HCP/HCT/113/98. Washington: WHO, OPS; 1998. 16. Espinal CA, Cortes GT, Guerra P, Arias AE. Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. Am J Trop Med Hyg 1985;34:675-80. 17. Magris M, Riggione F. Susceptibilidad del Plasmodium falciparum in vitro a la cloroquina, amodiaquina, quinina y pirimetamina-sulfadoxina en el estado Amazonas, Venezuela. Acta Científica Venezolana 1994;45 (Supl 1):250. 18. Blair S, Carmona-Fonseca J, Piñeros JG, Ríos A, Álvarez T, Álvarez G et al. Therapeutic efficacy test in malaria falciparum in Antioquia, Colombia. Malar J 2006;5:14. 19. Méndez F, Muñoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese J et al. Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 2002;156:230-8. 20. Noedl H, Wongsrichanalai C, Wernsdorfer WH. Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol 2003;19:175-81. 21. Kublin J, Richard W, Shankar A, Quintana J, Gilman R, Aramburu J et al. Molecular assays for surveillance of antifolate-resistance malaria. Lancet 1998;351:1629. 22. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley P et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 1997;176:1590-6.; https://revistabiomedica.org/index.php/biomedica/article/view/239Test

الإتاحة: https://revistabiomedica.org/index.php/biomedica/article/view/239Test

المؤلفون: Carmona-Fonseca, Jaime, Arango, Eliana, Blair², Silvia

المصدر: Biomédica, Volume: 28, Issue: 2, Pages: 195-212, Published: JUN 2008

مصطلحات موضوعية: antimalarials, sulfadoxine, pyrimethamine, antipalúdicos, pirimetamina, falciparum, amodiaquine, sulfadoxina, Plasmodium falciparum, malaria, Artemisia annua, malaria falciparum, amodiaquina

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od_______618::cb9c494b2a895ef46dbc4bf8630cbad6Test
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-41572008000200005&lng=en&tlng=enTest

المؤلفون: Marquiño Quesada, Wilmer

المصدر: Instituto Nacional de Salud
Repositorio Institucional-INS
INS-Institucional
instacron:INS

مصطلحات موضوعية: Vigilancia Epidemiológica, Malaria Falciparum, Brote de Enfermedades, Malaria

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______3056::ac7c886385d70d717ce2ab0c3252b110Test
http://repositorio.ins.gob.pe/handle/INS/866Test

عناروين إضافية: Gametocitemia en malaria por Plasmodium falciparum tratada con amodiaquina o artesunato

المصدر: Biomedica; Vol. 28 No. 2 (2008); 195-212; Biomédica; Vol. 28 Núm. 2 (2008); 195-212; 2590-7379; 0120-4157

مصطلحات الفهرس: malaria/ terapia, malaria falciparum, Plasmodium falciparum, antipalúdicos, amodiaquina, sulfadoxina, pirimetamina, Artemisia annua, malaria/ therapy, malaria, falciparum, antimalarials, amodiaquine, sulfadoxine, pyrimethamine, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://revistabiomedica.org/index.php/biomedica/article/view/91Test
https://revistabiomedica.org/index.php/biomedica/article/view/91/89Test
https://revistabiomedica.org/index.php/biomedica/article/view/91/89Test
*ref*/Day  KP, Hayward RE, Dyer  M. The biology of Plasmodium falciparum transmission stages. Parasitology. 1998; 116 ( Suppl.): S95-109. 2. Eichner M, Diebner  HH, Molineaux L, Collins  WE, Jeffery GM, Dietz K. Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg. 2001; 95: 497-501. 3. Robert  V, Boudin  C. Biologie de la transmission homme-moustique du Plasmodium. Bull Soc Pathol Exot. 2003; 96: 6-20. 4. Field JW, Shute PG. The microscopic diagnostic of human malaria. In: A morphological study of the erythrocytic parasites. Kuala Lumpur: Government Press; 1956. p. 142. 5. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V. Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J. 2004; 3: 24. 6. Rogers NJ, Hall BS, Obiero J, Targett  GA, Sutherland CJ. A model for sequestration of the transmission stages of Plasmodium falciparum: adhesion of gametocyte-infected erythrocytes to human bone marrow cells. Infect Immun. 2000; 68: 3455-62.  7. Lensen A, Bril A, van de Vegte M, van Gemert  GJ, Eling W, Sauerwein R. Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. Exp Parasitol. 1999; 91: 101-3. 8. Sinden RE, Smalley ME. Gametocytogenesis of Plasmodium falciparum in vitro: the cell-cycle. Parasitology. 1979; 79: 277-96. 9. Smalley ME, Sinden  RE. Plasmodium falciparum gametocytes their longevity and infectivity. Parasitology. 1977; 74: 1-8. 10. Drakeley C, Sutherland  C, Bousema JT, Sauerwein RW, Targett GA. The epidemiology of Plasmodium falciparum gametocytes: weapons of mass dispersion. Trends Parasitol. 2006; 22: 424-30. 11. Carter  R, Miller  LH. Evidence for environmental modulation of gametocytogenesis in Plasmodium falciparum in continuous culture. Bull World Health Organ. 1979; 57 ( Suppl